Clinical Trials
5 trialsNCT06448169 2024-06-07
Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer
Shandong University
Unknown
NCT05176964 2023-09-25
Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
Fujian Medical University Union Hospital
Unknown
NCT06034964 2023-09-13
Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Unknown
NCT04996459 2021-08-09
Tislelizumab in the Systematic Treatment of Advanced Hepatocellular Carcinoma
Fudan University
Unknown
NCT04771715 2021-02-25
Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer
Peking Union Medical College Hospital
Unknown